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Abstract
Mycetoma is a chronic granulomatous disease. It is classified into eumycetoma caused by fungi and actinomycetoma due to
filamentous actinomycetes. Mycetoma can be found in geographic areas in close proximity to the Tropic of Cancer. Mexico
is one of the countries in which this disease is highly endemic. In this retrospective study we report epidemiologic, clinical
and microbiologic data of mycetoma observed in the General Hospital of Mexico in a 33 year-period (1980 to 2013). A total
of 482 cases were included which were clinical and microbiology confirmed. Four hundred and forty four cases (92.11%)
were actinomycetomas and 38 cases (7.88%) were eumycetomas. Most patients were agricultural workers; there was a male
predominance with a sex ratio of 3:1. The mean age was 34.5 years old (most ranged from 21 to 40 years). The main affected
localization was lower and upper limbs (70.74% and 14.52% respectively). Most of the patients came from humid tropical
areas (Morelos, Guerrero and Hidalgo were the regions commonly reported). The main clinical presentation was as tumor-
like soft tissue swelling with draining sinuses (97.1%). Grains were observed in all the cases. The principal causative agents
for actinomycetoma were: Nocardia brasiliensis (78.21%) and Actinomadura madurae (8.7%); meanwhile, for eumycetomas:
Madurella mycetomatis and Scedosporium boydii (synonym: Pseudallescheria boydii) were identified. This is a single-center,
with long-follow up, cross-sectional study that allows determining the prevalence and characteristics of mycetoma in
different regions of Mexico.
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Introduction
Mycetoma is a chronic granulomatous disease, associated with a
progressive, inflammatory reaction that clinically presents as
tumor-like soft tissue swelling with sinus tract formation that
drains purulent material containing grains. Mycetoma usually
results of traumatic implantation of soil organisms on subcutane-
ous tissue; can be classified as eumycetoma or actinomycetoma
depending on whether the infection is caused by filamentous fungi
or aerobic filamentous actinomycetes, respectively [1,2,3].
Mycetoma represents a classical neglected disease that primarily
affects the poorer populations and rural regions of Africa, Latin
America, and Asia at latitudes defined as the ‘‘mycetoma belt’’
where higher mycetoma frequencies are observed. This region is
located around the Tropic of Cancer, between latitudes 15u South
and 30u North, encompassing the countries with the highest rates
of infection including Sudan, Somalia, Senegal, India, Yemen,
Mexico, and Venezuela [1,4,5]. The predominant climate of the
‘‘mycetoma belt’’ is subtropical and dry tropical with an annual
average rainfall of about 500–1000 mm and temperatures ranged
from 10–20uC to 20–40uC, respectively. This region is character-
ized by low humidity and low annual rainfall with well-defined
alternating rainy and dry seasons. Actinomycetomas caused by
Nocardia spp. occur mostly in regions with higher humidity, while
actinomycetoma caused by Actinomadura spp. and Streptomyces
spp. or eumycetoma occur in drier areas with low relative
humidity [1,3,4,5].
Most causative agents of mycetoma, including fungi and
actinomycetes, have been isolated from soil, decaying organic
matter, plants and thorns; and, the disease is usually associated
with traumatic injury followed by inoculation of the microorgan-
ism propagule. There are three main factors associated with the
establishment of disease: inoculum size, immune status of the host,
and hormonal adaptation (based on the observation that men
typically develop the disease) [1,3,6,7,8,9].
Epidemiological data from different areas demonstrate that
males are more affected (sex ratio 3–4:1), ranging in age between
the third and fourth decades of life (20–40 years). Some studies
have reported that 3–5% of cases affect children committed to
field-work [6,10,11]. Mycetoma is common in persons that work
in rudimentary conditions without protective garments or shoes
leading to the presentation of the illness primarily in poor rural
workers or homemakers that participate in outdoor activities.
Nearly all cases affect the lower limbs (75%), especially the foot
and lower limbs. The nature of the patient’s occupation also
influences disease presentation, for example lumberjacks and
sugarcane carriers generally present with mycetoma on the back
[6,10,11].
The incubation period is unknown, disease symptoms present
months to years after traumatic inoculation, depending on the
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inoculum size, strain virulence, and the host’s immune response
[7]. Because reporting mycetoma cases is not mandatory, the
worldwide incidence is unknown; however, a recent published
meta-analysis by van de Sande [11] reported incidence rates of
3.49 and 1.81 per 100,000 habitants in Mauritania and Sudan,
respectively; while Mexico showed the highest rate in Latin
American. Although a separate study reported that the number of
cases per year in Sudan, Mauritania, and Mexico were 106, 80.7,
and 73, respectively [6], several cases are probably not reported.
The objective in this study was to provide epidemiological,
clinical and microbiological data of mycetoma in different regions
on Mexico, presenting at a public single center, the General
Hospital of Mexico (specialty hospital).
Materials and Methods
The Institutional Review Board approved the retrospective
(cross-sectional) analysis of the database and clinical records of the
Mycology Department of the Dermatology Service at the General
Hospital of Mexico, patients were enrolled between January 1980
and December 2013 (34 years). We included all cases of mycetoma
confirmed by microscopic observation of grains by direct
examination with 10% potassium hydroxide (KOH), saline
solution, and lugol solution. The culture media used were
Sabouraud dextrose agar and Yeast extract agar, however, when
infection by Actinomadura madurae was suspected, Lowenstein-
Jensen agar, and BHI agar (Brain Heart Infusion) were used.
Histological examination was performed in some cases using
hematoxylin and eosin (H&E), Grocott’s methenamine silver
(GMS), and Periodic acid–Schiff (PAS)
Actinomycetes identification was carried out using micro
morphological criteria (Gram and Kinyoun stains) as well as
biochemical and major phenotypic tests such as urease production,
hydrolysis of casein, gelatin, tyrosine, xanthine, hypoxanthine
substrates and, growth at 45uC [12,13]. Fungal agent identification
was based on morphological and reproductive form criteria and on
biochemical tests. Some strains were identified using molecular
techniques (by amplification and sequence analysis of ribosomal
DNA. the internal transcribed spacer region (ITS), the translation
elongation factor 1 alpha (EF1-a), the partial beta tubulin gene
(TUB), and the small subunit of the nuclear ribosomal RNA gene
[nucSSU]). General epidemiologic and clinical data were extract-
ed from clinical records. All patients remained anonymous and
descriptive statistics were used to analyze the data.
Results
A total of 482 mycetoma cases were included in the present
study, one patient presented simultaneously two different myce-
tomas. Demographic data are described in Table 1.
Figure 1 illustrates the age distribution of mycetoma, and
Figure 2 the geographic mycetoma distribution in Mexico. The
Pacific Ocean zone including Morelos, Guerrero, and Oaxaca
accounted for 284 cases (58.92%) and the Gulf of Mexico zone
(including Hidalgo and Veracruz) accounted for 162 cases
(33.60%). The remaining 36 cases presented in other states
including Chiapas, Tabasco, Puebla, Michoacan, Colima, Jalisco,
San Luis Potosi, Durango, Chihuahua, and Baja California.
Most cases were actinomycetomas (92.11%) with a male to
female ratio of 2.8:1. However, this ratio changes in cases due to
Actinomadura madurae, of the 42 cases 13 (30.06%) were males
and 29 (69.04%) were females with a male:female ratio of 1:2.2.
Age ranges were classified in decades, the mean age was 34.5 years
old (range 7–92 years). Pediatric cases (,18 years old) were 20/
482 (4.14%) and 5/482 cases (1.083%) were younger than 15 years
old.
Lower limbs were affected in 341 cases (70.74%). Three
hundred one cases (62.44%) occurred in the foot, 70 cases
(14.52%) affected the upper limbs (36 cases on the hands [7.46%]
and 34 on the arms [7.05%]). The trunk was involved in 49 cases
(10.16%), 38 (7.88%) of those included back and shoulders. All
cases involving multiple sites were associated with multiple
traumatic inoculations. In regards to clinical presentation,
mycetomas were classified as follows: 468 cases as tumor-like with
draining sinuses (97.1%); eight cases as tumor–like without sinuses
(1.65%); four cases as verrucous plaque (0.82%) and two as cystic
form (0.41%). Eight patients (1.6%) presented lymphatic spread
from the original mycetoma lesion: six from the foot to the
inguinal area and two from the back to the axillary region.
(Figure 3) One patient presented with two mycetomas, each with a
distinct causative agent: the one affecting the right foot was caused
by Madurella mycetomatis, and the second one affecting the left
foot was caused by Fusarium solani complex.
Etiological agents were identified in 472/482 cases (98.34%).
The agent was found in all of the actinomycetoma cases (n = 444
cases). In 430 cases (89.2%) the microorganisms were isolated and
identified, and the remaining 14 cases were classified according to
the grains observed during direct examination and/or histopath-
ologic analysis. Two cases had double concurrently causative
agents: N. asteroides s. l.+N. brasiliensis [14] and N. brasiliensis+
A. madurae. Thirty-eight cases were eumycetomas and in 30/38
cases the etiological agents were isolated. Of the remaining seven
cases (four hyaline and three melanized-type) only grain observa-
tion at direct microscopy was detected without identifying the
causative fungi (Table 2) [15,16].
Discussion
Mycetoma is a chronic granulomatous disease generally
affecting low-income people including agricultural workers,
peasants, or rural workers laboring with limited or no protective
garments and soiled tools. The majority of cases (62%) described
Author Summary
Mycetoma is a chronic, subcutaneous granulomatous
disease that usually begins after traumatic inoculation
with causative microorganisms. Based on its etiology,
mycetoma is referred to eumycetoma when the infection
is caused by filamentous fungi, and actinomycetoma when
the infection is due to aerobic actinomycetes (in Mexico
predominantly Nocardia brasiliensis). Establishing the
etiology is extremely important since it impacts treatment
regimens. Mycetoma typically presents around the Tropic
of Cancer between latitude 15u South and 30u North (also
known as ‘‘mycetoma belt’’) affecting poor populations in
Africa, Asia, and Latin America, including Mexico, which
represents a highly endemic area with higher frequencies
of actinomycetomas. Mycetoma usually affects males
(male:female ratio of 3:1), agricultural or rural workers
(age range 20–40 years) that typically do not have access
to protective equipment. The main clinical presentation is
as soft tissue swelling with sinus tract formation draining
grains, which leads to diagnosis. The foot is the most
commonly affected localization; however, when disease
presents in high risk areas, such as the trunk, it can
disseminate to the lungs and spinal cord. This report
represents a single center study which provides epidemi-
ologic, clinical, and microbiological data of mycetoma
cases in different regions of Mexico.
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in this report affected the foot, supporting previous reports
[3,5,6,10] and one meta-analysis [11] that described foot as the
most common site of infection (68.7% of cases). Since mycetoma
presented most often on the feet of individuals living in the Indian
endemic region, it explains why initial reports mentioned it as
‘‘Madura foot’’ [11,17,18,19]. Due to the predilection for feet,
mycetoma control could be achieved by using appropriate
footwear and clothing that protects the limbs. However, it should
be emphasized that people living in endemic regions sometimes
wear open-toed shoes, mainly due to the warm climate and
therefore are less protected against potential trauma [1,5,20,21].
Mycetoma is associated with high morbidity and low mortality;
however, the socioeconomic impact is significant; therefore
patients are unable to work, resulting in decreased family income.
In addition, treatments are expensive and difficult to maintain due
to prolonged course of the disease. Almost all countries located in
Table 1. Demographic data of the study population.














Lower limbs (feet, legs) 341 (70.74)
Upper limbs (hands, arms) 70 (14.52)
Trunk (anterior and posterior thorax, abdomen) 49 (10.16)
Head and neck 4 (0.82)
Several locations 10 (2.07)
Lymphatic dissemination (e.g., foot-inguinal region) 8 (1.65)
doi:10.1371/journal.pntd.0003102.t001
Figure 1. Age distribution of the mycetoma patients.
doi:10.1371/journal.pntd.0003102.g001
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Figure 2. Geographical location of the five states with the higher incidence of mycetoma in Mexico.
doi:10.1371/journal.pntd.0003102.g002
Figure 3. a) Foot mycetoma due to A. madurae. b) Back mycetoma with multiple sinuses caused by N. brasiliensis. c) Extensive mycetoma in an
adolescent due to N. brasiliensis. d) Exophytic or tumoral mycetoma caused by Fusarium solani complex.
doi:10.1371/journal.pntd.0003102.g003
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the ‘‘mycetoma belt’’ do not provide free quality health services or
medical insurance [5,20,21].
The classical clinical presentation of mycetoma should lead to
simple diagnosis based on the identification of a swelling zone with
multiple sinus tracts; however, there is a significant lack of
information between patients and clinicians, leading to delayed
diagnosis and late referral to hospital, and consequently inade-
quate therapeutic response [5,7,8].
This study examined nearly 500 mycetoma cases from a single
public hospital, helping to control for variables and facilitated the
isolation and identification of the causative agents (the causative
agent was classified in most of the cases). Ninety two percent were
actinomycetoma and 8% were eumycetoma, in accordance with
previous studies [10]. This result differed from one report [6] that
identified 3.5% eumycetoma cases this is probably due to the
difficult diagnosing these cases until they are finally referred to
specialty hospitals. Reports from Latin America [22,23,24,25]
and, particularly, studies conducted in Mexico show a predom-
inance of actinomycetoma, in contrast to those made in Africa,
India, and Asia where cases of eumycetoma predominate
[17,20,26,27,28,29]. This epidemiological difference can be
explained by differences in climate and other environmental
factors. The effect of climate is observed in mycetoma cases
reported in India [17,18,19] where the majority of actinomyce-
toma occur in the northern region, where the climate is
subtropical and has a higher annual rainfall; while, eumycetomas
occur more often in the southern where the climate is dry
tropical, has a low relative humidity, and more constant
temperatures. In Mexico, eumycetomas occur in drier areas.
This study provides a more accurate number of cases of
mycetoma in Mexico (73 new cases per-year) [6], we believe
that mycetoma remains difficult for clinicians to diagnose, for that
several cases may be under diagnosed and therefore underre-
ported [1,3,11].
In our study, we observed that mycetoma primarily affects men,
with a male:female ratio of almost 3:1 in our study, in concordance
with a previous report about mycetoma incidence in Mexico [6].
This male predominance of micetoma can be attributed to
occupational and hormonal aspect [8,9]. The role of hormones in
disease susceptibility may be explained by the few cases of
mycetoma in children and the rapid growth of the lesions and
increased in severity during pregnancy. Interestingly, the observed
Table 2. Etiologic agents of actinomycetoma and eumycetoma.
Etiologic agent Number (%)
Actinomycetomas Total: 444 (92.11)
Nocardia brasiliensis 377 (78.21)
Nocardia asteroides complex 4 (0.82)
Nocardia otitidiscaviarum (Syn: Nocardia caviae) [14]* 2 (0.41)
Nocardia spp 4 (0.82)
Actinomadura madurae 36 (7.46)
Actinomadura pelletieri 2 (0.41)
Streptomyces somaliensis 3 (0.62)
A. madurae grains (Identified by KOH and biopsy) 6 (1.24)
Nocardia spp. grains (Identified by KOH and biopsy) 8 (1.65)
Double etiology
N. brasiliensis+N. asteroides s.l. [14] 1 (0.20)
N. brasiliensis+A. madurae 1 (0.20)
Eumycetomas Total: 38 (7.88)
Black grains (total) 26 (5.39)
Madurella mycetomatis 15 (3.11)
Trematospheria grisea (Syn. Madurella grisea) 4 (0.82)
Medicopsis romeroi (Syn. Pyrenochaeta romeroi) 1 (0.20)
Exophiala jeanselmei 1 (0.20)
Cladophialophora bantiana (CBS 16363) [15]* 1 (0.20)
Cladophialophora mycetomatis (CBS 122637) [16]* 1 (0.20)
Not identified. (Confirmed by observation of black grains with KOH and biopsy) 3 (0.62)
Hyaline grains (white or yellowish): total 12 (2.48)
Scedosporium boydii (Syn. Pseudallescheria boydii) 3 (0.62)
Fusarium solani complex (CBS: 135554) 2 (0.41)
Acremonium sp 1 (0.41)
Aspergillus nidulans 1 (0.20)
Microsporum canis 1 (0.20)
Not identified 4 (0.82)
* [14,15,16] previously reported.
doi:10.1371/journal.pntd.0003102.t002
Mycetoma: Report of 482 Cases
PLOS Neglected Tropical Diseases | www.plosntds.org 5 August 2014 | Volume 8 | Issue 8 | e3102
change of male:female ratio in cases of mycetoma caused by A.
madurae (male:female ratio of 1:2.2) is partly due to this
microorganism is not affected by progesterone and testosterone
as with Nocardia brasiliensis [8,9].
Figure 1 shows mycetoma is most prevalent in the third decade
of life (63.26%), which represents the most productive ages.
The mean age was 34.5 years, similar to observations were
made by van de Sande [7]. Some cases were reported in elderly,
however we must consider that the infection may have started
many years ago, suggesting that these individuals may have
acquired the disease in youth. Moreover, only 4% of the cases
were reported in patients ,18 years old similar to previously
reported studies [6,30]. The percentage of children infected in our
study (and other reports [6,30]) differed from a report by Fahal et
al. [31] that described a 15% infection rate (n = 722) in children in
Sudan, this was probably due to their outdoor work activities.
However, the same study reported trauma in only 22.5% patients
suggesting that different mechanisms of infection that deserve to be
clarified [1,31].
The main clinical presentation was tumor-like with draining
sinuses; cases presented as tumor-like without sinuses and cystic
form were all eumycetomas; verrucous-plaque presentation was
rare, the last one is very important since its differential diagnosis
include verrucous-tuberculosis, chromoblastomycosis and nontu-
berculous mycobacterial diseases. Although lower limbs (predom-
inantly feet) were most commonly affected by mycetoma in our
population (similar to the majority of previous reports [6,10,25]) it
is interesting that the trunk was affected in about 10% of cases
(predominantly back and shoulders). A previous Mexican report
[6] described and incidence rate of the trunk in 19% of the cases,
which was significantly different from the 1.4% rate described for
these cases in Sudan [11]. These differences in anatomic regions
affected may be explained due to occupation differences; patients
in Mexico usually carry wood, sugarcane, or diverse materials on
their backs. Mycetoma affecting the trunk should be considered of
poor prognosis because of the proximity of lungs, spinal cord, and
viscera [32]. It is also important to emphasize that cases
presenting with multiple infections were described in immuno-
competent patients that suffered multiple traumatic inoculations.
Cases associated with lymphatic spread (1.65%) are typically seen
in immunocompromised patients (malnutrition, immunosuppres-
sants, malignant tumors, and chronic alcoholism).
Nocardia spp. was the main etiological agent (82.32% of cases),
being N. brasiliensis the predominant species (78.21%). The
strains were identified using phenotypic tests that lead to the
identification of two more species: N. asteroides complex and N.
otitidiscaviarum (formerly N. caviae) [14,33]. Molecular biology
techniques such as PCR and sequencing of 16S rRNA and the
hsp65 gene allow the correct identification and classification of
Nocardia species [13]. For example, N. mexicana, N. harenae, and
N. takedensis were isolated from Mexican patients [34,35,36]. The
second most common causative agent was A. madurae; distributed
worldwide [11], which is easily identified due to the larger (1–
3 mm) white-yellowish, soft, wide-fringed border grains. Regard-
less, A. madurae is more difficult to isolate than Nocardia species,
which regularly grow in rich culture media such as Lowenstein-
Jensen, BHI-agar. Morphologic analyses leads to the identification
of the causative agent, however, confirmation is carried out using
phenotypic and temperature tests [12]. Other etiologic agents
include A. pelletieri and S. somaliensis commonly found in Africa
and Asia. Remarkably, the two cases presented with mixed
infections following traumatic inoculation were due to N.
brasiliensis+N. asteroides s.l. and N. brasiliensis+A. madurae,
respectively, both presented in immunocompetent patients [14].
The causal agents of eumycetoma represented only 8% of our
series, melanized fungi was the most commonly observed (26
cases, 5.39%). Of these, Madurella mycetomatis was the foremost
isolated fungi, found in 15 cases, and also considered responsible
for 25% of cases worldwide, mainly in Africa and Asia [11].
Some cases have a well-defined history of trauma (e.g., thorn
pricks) prior to mycetoma development; however, in some cases a
well-defined traumatic event was not identified, de Hoog [37]
recently noted that M. mycetomatis is a close relative to dung-
inhabiting fungi and suggested that the natural habitat of this
fungus could therefore also be dung; trauma or repeated contact
with cattle dung could act as an adjuvant for inoculation of
causative agents of mycetoma. Identification of Madurella species
has been hampered by the absence of sporulation leading to
confusion during the identification process. The use of molecular
techniques for the identification of specific regions and genes
(e.g., rRNA, ITS, parcial b-tubulin gene, RNA polymerase II
subunit 2 gene) has defined Madurella species as a cryptic
complex belonging to the order Sordariales, consists primarily of
M. mycetomatis, M. fahalii, M. tropicana, and M. pseudomyce-
tomatis [38]. Identification of the infecting agent is critical since
differences in thermal adaptation and susceptibility to antifungal
agents exist between strains. M. grisea has been reclassified and
now belongs to the order Pleosporales and named Trematospheria
grisea. It should be noted that the latter was more frequently
reported as a cause of mycetoma than M. mycetomatis in a recent
report from Mexico [6]; however, difficulties in morphological
and phenotypic identification could have led to confusion. Other
melanized fungi further characterized by molecular biology
techniques was Exophiala jeanselmei and Cladophialophora
bantiana, which are common agents of phaeohyphomycosis
[15]; and Cladophialophora mycetomatis, considered new specie
[16]. Regarding hyaline fungi, Scedosporium boydii (Syn:
Scedosporium apiospermum, Pseudallescheria boydii), was the
foremost isolated strain (similar to other studies) [6,11,24,26].
Mycetomas due to Fusarium have been previously described
[39,40], we found F. solani in two cases; interestingly, one of
them was microscopically classified as F. chlamydosporum, but
was reclassified using molecular biology as part of the Fusarium
solani complex (CBS 135554). One case resulted from infection
with Aspergillus nidulans, an agent rarely reported [41] and
identified morphologically for the presence of Hu¨lle cells. A case
resulting from Microsporum canis infection was classified as
pseudomycetoma [42] because of the rarity of the agent as a
mycetoma pathogen and usually development as consequence of
a chronic tinea capitis, typically seen in immunocompromised
patients in the absence of traumatic inoculation [42,43].
The study has limitations inherent to its design, however,
provides important information about the status of mycetoma
in Mexico. The study results can be generalized only to our
population (Mexico); although the geographical areas studied
has similarities with other world regions in terms of climate,
distribution of etiologic agents and sociocultural conditions.
Mycetoma fulfills all the criteria of a neglected tropical disease
[20,21,44]. It is extremely important to monitor cases and their
causative agents, as a mean to understand the epidemiology of the
disease, and to establish interventions for prevention, treatment
and rehabilitation.
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